Engage with inspiring events and funding opportunities

Posts tagged Medicine

Funding for precision medicine technologies

Innovate UK will invest up to £5 million in innovation projects to support the development of precision medicine (PM) technologies. Even the best medicines are not equally effective in all patients and have variable degrees of tolerability. Disease processes and treatment choices can vary from person to person even though...

Pitch for Partnership in Immunology

Join Future Worlds Medicine and watch six research teams from the University of Southampton pitch their disruptive immunology ideas to an elite panel of top scientists from global pharma companies, with the hope of securing valuable industry collaborations. Companies already confirmed for the panel include AstraZeneca, MedImmune, Pfizer, Roche, and Gilead Sciences. This promises...

Tools For Partnering Workshops

Join the Future Worlds network for one of two idea exchange workshops hosted by Echo Zhang from Inova Software. Searching for the right opportunities and accumulating masses of competitive intelligence is a universal problem for life science companies and universities. Whether you are looking at licensing, collaborations, funding or acquisition,...

Biotech and pharma futures – our mentors’ prognoses

Biotech and pharma form one of the world’s largest industries, yet it is still relatively new with great potential for driving medical progress through pioneering advances in research and innovation. Future Worlds Medicine supports the groundbreaking research taking place at the University of Southampton and as our students, researchers and scientists...

David Tordrup

As Managing Director of consulting business Triangulate Health Ltd, health economist David Tordrup works with a broad range of clients from the public and private sector to provide insight and analysis in the interface between life sciences, economics and policy. His assignments include projects in pharmaceutical economics, policy research, economic...

Jim Wicks

Biotech entrepreneur Jim Wicks co-founded DNA detection-based business Primerdesign in 2004 from within the University’s Faculty of Medicine. Starting on a shoestring budget, the company delivered highly profitable accounts from year one, resulting in a multimillion pound turnover and a world-renowned reputation in their field. Following the successful sale of the business, Jim guides...

Annie Jullien Pannelay

Annie Jullien Pannelay’s career and experience span over multiple areas within the financial, pharma and health policy sectors. She is a shareholder in a number of startups that she supports and her current work as an independent adviser focuses on European health policy projects. In her role as Principal Consultant...

Brigitte Lavoie

Brigitte Lavoie is creating connections between academia and industry that are helping improve people’s lives through ground-breaking health research. She is facilitating new partnerships in the health and pharma scene as an Industry Collaboration Manager for the University of Southampton and leads the Future Worlds Medicine initiative. A passionate neuroscientist,...

Simon MacKenzie

Simon MacKenzie believes that communication is key to developing a successful business. “It’s like learning language and the quicker you learn how to communicate well, the better,” he explains. With more than 15 years’ experience of senior business and scientific roles, in drug discovery, innovation, business development and collaborative alliance...

Natasha Nater

As part of the Future Worlds Medicine team, Natasha Nater is producing inspiring events and compelling creative content to support aspiring entrepreneurs in healthcare to develop high impact businesses. Natasha brings her combined experience in marketing theory and video production to the team along with organisation skills developed from previous...

BioFIT 2017 – reflections on an exhilarating event

Exhibiting at BioFIT, Europe’s leading life sciences partnering event, was a fantastic opportunity for the Future Worlds team to promote the innovative medical commercial opportunities being developed by researchers and students at the University of Southampton. It was also a great chance for the team to make new connections with...

BioFIT – Day Two – Renovos pitches in Start-up Slam

After an exciting and successful first day at BioFIT 2017, the Future Worlds team arrived early on Wednesday morning at the Palais de la Musique et des Congrès convention centre, ready for another energetic day at Europe’s leading life sciences partnering event in Strasbourg. After filming some footage for the...

BioFIT – Day One – Medical spinouts star in Strasbourg

The Future Worlds team arrived at the Palais de la Musique et des Congrès in Strasbourg early on Tuesday morning, poised to exhibit the University of Southampton’s ground-breaking medical innovations to a range of guests and medical companies from around the world at Europe’s leading partnering event, BioFIT 2017. Future Worlds...

Future Worlds Medicine launch injects ‘energy and drive’ into university innovations

A growing entrepreneurial culture among medical innovators at the University of Southampton was praised by senior industry leaders at the official launch of the Future Worlds Medicine initiative in London. Five medical entrepreneurs pitched Southampton research and technologies to a packed audience of industry experts, entrepeneurs and investors at The...

Spinout Stories with Ali Tavassoli – ‘From the lab to the clinic, and back again’

Enterprise Champion Professor Ali Tavassoli leads an interdisciplinary team of scientists developing novel chemical tools that will inspire new therapeutics, expanding on a research platform he co-developed in a five-year spell at Penn State University in the USA. This week, he shared his inspirational journey ‘From the lab to the...

Simon Kerry

Simon Kerry is a business expert with expansive experience of creating and developing innovative life science businesses.  He enjoyed success as the CEO of University of Southampton spinout Karus Therapeutics, where he took the company from a startup phase and progressed it through to a clinical stage cancer company.  Simon...

Improving treatment for premature babies – an entrepreneur’s journey ‘from bench to bedside’

Child Health Professor Howard Clark has founded University spinout Trimunocor to combat neonatal chronic lung disease. This week, he discussed his inspirational journey ‘from bench to bedside’ as he approaches clinical trials for his innovative protein fragment. Watch his full talk in the video panel above or read on for...

Sandrine Willaime-Morawek

Sandrine Willaime-Morawek is promoting interactions between clinical neuroscience research and industry as an Enterprise Champion for the University of Southampton’s Faculty of Medicine. An expert in stem cells and brain repair, she divides her time between research, teaching and enterprise in a fulfilling role building on close to 20 years...

John Holloway

Professor John Holloway is helping academics and researchers from the University of Southampton impact the world around them as Associate Dean Research for the institution’s Faculty of Medicine. A Professor of Allergy and Respiratory Genetics, he is testament to the variety that can be obtained in a scientific career and...

Salim Khakoo

Salim Khakoo is engineering a culture of enterprise within the University of Southampton’s esteemed Faculty of Medicine through innovative new programmes with industry. A leading expert in the human body’s natural killer cells, he is advancing research as a Professor of Hepatology and Director of Biomedical Research in the Institute...

Accelerating medical innovations towards global impact – introducing Future Worlds Medicine

University innovators are set to break into the healthcare and pharmaceutical markets through Future Worlds with support from the Medical Research Council (MRC). Future Worlds Medicine will grow a culture of innovation and entrepreneurship within the medical and healthcare sector, powered by the ecosystem’s unique network of mentors, investors and industry...